Quick Answer
Nasus Pharma Ltd reported R&D Expense of $2.24 million for fiscal year 2025.
Nasus Pharma Ltd R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $2.24M | +567.8% |
| 2024 | $335.0K | -40.9% |
| 2023 | $567.0K | — |
- Nasus Pharma Ltd showed an increase of +567.8% in R&D Expense compared to the prior fiscal year.
- Over the 2023–2025 period, Nasus Pharma Ltd’s r&d expense has grown by 294.5% (from $567.0 thousand to $2.24 million).
- The most recent figure is from Nasus Pharma Ltd’s fiscal year 2025 report (Form 20-F), filed with the SEC on March 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: